Melanotan-2 (MT-2) is a synthetic melanocortin receptor analog originally developed at the University of Arizona and studied in pigmentation, appetite and central-nervous-system research.
Non-selective agonism of melanocortin receptors MC1R–MC5R.
Historical dermatology and appetite research; ongoing preclinical work.
- Pigmentation and photobiology research
- Appetite and satiety studies
- Melanocortin-pathway investigation
PeriodDoseUnits (U-100)
Research protocol0.25–1 mg—
Adjust dose based on study design and tolerability. Consult your protocol.
For research use only. Not for human or veterinary consumption. Not FDA-approved for the treatment or prevention of any disease.